Kenvue Inc.
NYQ: KVUELive Quote
📈 ZcoreAI Score
Our AI model analyzes Kenvue Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get KVUE Z-Score →About Kenvue Inc.
Consumer Defensive
Household & Personal Products
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
📊 Fundamental Analysis
Kenvue Inc. demonstrates exceptional profitability, with a profit margin of 9.7%.
The company recently reported 3.2% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 14.4%, which suggests room for improvement in capital utilization.
At a current price of $17.35, KVUE currently sits at the 30th percentile of its 52-week range (Range: $14.02 - $25.17).
💰 Valuation Insight
KVUE is valued broadly in line with the sector at a PE of 22.83. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
✅
Profit Margin
Excellent
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$33.31B
Trailing P/E
22.83
Forward P/E
14.38
Beta (5Y)
0.57
52W High
$25.17
52W Low
$14.02
Avg Volume
38.97M
Day High
Day Low